This compound is a modified uridine analog, functioning as a nucleotide metabolism inhibitor. It is a pharmaceutical raw material used in research and manufacturing processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 18771-50-1
Derquantel
pharmaceutical raw material
Abacavir sulfate
pharmaceutical raw material
Temazepam acetate
pharmaceutical raw material
Tetrabutylammonium benzoate
pharmaceutical raw material
(4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one
pharmaceutical raw material
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one
UCKYOOZPSJFJIZ-XVKVHKPRSA-N
C1CN(C(=O)NC1O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O